{"filing":{"accession_number":"0001193125-26-380189","cik":"0001826470","ticker":"WOOF","company_name":"Petco Health \u0026 Wellness Company, Inc.","form":"8-K","filing_date":"2026-09-02","report_date":"2026-09-02","primary_document":"woof-20260902.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1826470/000119312526380189/woof-20260902.htm"},"events":[{"id":31304,"run_id":28718,"accession_number":"0001193125-26-380189","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Petco disclosed Q2 2026 financial results for the quarter ended August 1, 2026, reporting net sales of $1.5 billion, net income of $38.7 million, Adjusted EBITDA of $122.2 million, and comparable sales growth of 0.6%, with full-year outlook reaffirmation.","company_name":"Petco Health \u0026 Wellness Company, Inc.","ticker":"WOOF","filing_date":"2026-09-02","form":"8-K","submitted_at":null,"items":[{"id":34140,"accession_number":"0001193125-26-380189","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Petco's Q2 2026 financial results for the quarter ended August 1, 2026. The press release, filed under Item 2.02 (Results of Operations and Financial Condition), reports net sales of $1.5 billion, net income of $38.7 million, and Adjusted EBITDA of $122.2 million, along with comparable sales growth and full-year outlook reaffirmation. The disclosure includes detailed financial statements and management commentary typical of quarterly earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-02T20:12:16.569703+00:00","company_name":"","ticker":null,"filing_date":""},{"id":34141,"accession_number":"0001193125-26-380189","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses Petco's second quarter 2026 financial results, including net sales of $1.5 billion, comparable sales growth of 0.6%, operating income of $47.8 million, and net income of $38.7 million. The press release (Exhibit 99.1) presents comprehensive quarterly results with detailed financial statements, management commentary, and full-year guidance reaffirmation. This is a standard earnings release disclosure material to investors assessing the company's financial performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-02T20:12:16.569703+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34140,"accession_number":"0001193125-26-380189","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Petco's Q2 2026 financial results for the quarter ended August 1, 2026. The press release, filed under Item 2.02 (Results of Operations and Financial Condition), reports net sales of $1.5 billion, net income of $38.7 million, and Adjusted EBITDA of $122.2 million, along with comparable sales growth and full-year outlook reaffirmation. The disclosure includes detailed financial statements and management commentary typical of quarterly earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-02T20:12:16.569703+00:00","company_name":"Petco Health \u0026 Wellness Company, Inc.","ticker":"WOOF","filing_date":"2026-09-02"},{"id":34141,"accession_number":"0001193125-26-380189","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses Petco's second quarter 2026 financial results, including net sales of $1.5 billion, comparable sales growth of 0.6%, operating income of $47.8 million, and net income of $38.7 million. The press release (Exhibit 99.1) presents comprehensive quarterly results with detailed financial statements, management commentary, and full-year guidance reaffirmation. This is a standard earnings release disclosure material to investors assessing the company's financial performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-02T20:12:16.569703+00:00","company_name":"Petco Health \u0026 Wellness Company, Inc.","ticker":"WOOF","filing_date":"2026-09-02"}]}